Kyongbo Pharmaceutical Co., Ltd

KOSE:A214390 Stock Report

Market Cap: ₩154.2b

Kyongbo Pharmaceutical Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of A214390?
Owner TypeNumber of SharesOwnership Percentage
Employee Share Scheme308,0711.29%
Institutions447,8951.87%
Individual Insiders4,101,53117.2%
General Public8,672,31836.3%
Public Companies10,377,04543.4%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 13 shareholders own 63.72% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
43.4%
Chong Kun Dang Holdings Corp.
10,377,045₩66.9b0%no data
17.1%
Jang-Han Lee
4,086,035₩26.4b0%no data
1.33%
Samsung Asset Management Company, Ltd.
317,751₩2.0b0%0.01%
1.29%
Kyongbo Pharmaceutical Co., Ltd.Employee Stock Ownership Association
308,071₩2.0b0%no data
0.47%
Dimensional Fund Advisors LP
113,041₩729.1m13.4%no data
0.052%
Hyunsook Chae
12,496₩80.6m19.1%no data
0.045%
Kiwoom Asset Management Co., Ltd.
10,676₩68.9m0%0.01%
0.013%
Tae-Young Kim
3,000₩19.4m0%no data
0.012%
Hanwha Asset Management Co. Ltd.
2,879₩18.6m0%no data
0.007%
Mirae Asset Global Investments Co., Ltd.
1,669₩10.8m0%no data
0.0056%
KB Asset Management Co., Ltd.
1,344₩8.7m0%no data
0.0019%
Boston Partners Global Investors, Inc.
455₩2.9m0%no data
0.00033%
Korea Investment Management Co., Ltd.
80₩508.9k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/06 19:49
End of Day Share Price 2025/02/06 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Kyongbo Pharmaceutical Co., Ltd is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Kyung Jun MoonMERITZ Securities Co., Ltd.
Seung-Ho LeeNH Investment & Securities Co., Ltd.